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Introduction
Since the first successful clinical applications of cardio-
pulmonary bypass (CPB) in the early 1950s, the role of 
extracorporeal circulation has shifted progressively 
from a mere substitution of the heart and lungs towards 
the more complex field of organ perfusion.
Therefore, numerous investigations have been per-
formed to individuate which parameters might better 
associate with an improved organ perfusion during 
CPB.1–4 Consequently, the application of the physiologi-
cal concepts of metabolic needs to the setting of CPB 
promoted the concept of the so-called “goal-directed” 
perfusion.2 However, several surveys proved that the 
scientific data available at present are not yet sufficient 
to serve as evidence-based guidelines.5,6 The present 
study aims to evaluate the quality of organ perfusion 
during CPB and to structure a scoring system to assess 
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this quality by a comprehensive evaluation of flow-
dependent parameters.
Methods
This is a retrospective analysis of prospectively collected 
data from a single institution. The local Ethics Committee 
approved the study.
Inclusion criteria were age ≥18 years and surgery on 
CPB and aortic cross-clamping.
Exclusion criteria were surgery for aortic dissection, 
implantation of a ventricular assist device, heart trans-
plantation, off-pump surgery, surgery on cardiopulmo-
nary bypass without aortic cross-clamping, congenital 
heart disease, minimally-invasive surgery, chronic renal 
failure under replacement treatment and chronic respira-
tory insufficiency requiring domiciliary oxygen support.
Surgical technique and cardiopulmonary 
bypass
CPB and surgical techniques were standardized and did 
not change during the study period. In all patients, sur-
gery was performed through a median sternotomy. The 
CPB circuit and perfusion conduct were standardized for 
all patients and consisted of a phosphorylcholine-coated 
tubing set (Soring Group, Saluggia, Vercelli, Italy), a 
Stöckert roller pump (Stöckert Instrumente, Munich, 
Germany) and a hollow-fiber membrane oxygenator.
Heparin was given at a dose of 300 IU/kg to achieve a 
target activated clotting time over 480 sec. Systemic 
temperature varied according to the kind of surgery, 
never falling below 25°C in case of circulatory arrest.
The priming solution consisted of 500 ml of Emagel 
(Piramal Healthcare UK Ltd, Morpeth, Northumberland, 
UK) and 800 ml of Ringer’s acetate. Pump priming was 
reduced to an average of 800-1000 mL after aortic can-
nulation and retropriming.
Myocardial protection was always achieved with 
intermittent hyperkalaemic blood cardioplegia. 
Theoretical CPB flow was calculated, establishing a rate 
of 2.7 L/min/m2 and indexing it to an ideal body mass 
index of 25 kg/m2. Protamine was administered at the 
end of the operation to fully reverse heparin. Blood 
recovery with an autotransfusion device (Autotrans 
Dideco, Mirandola, Modena, Italy) was performed 
intraoperatively in all cases. A level of haemoglobin 
lower than 7 g/dl during CPB and before admission to 
the ICU suggested blood transfusion.
Data collection and definitions
Baseline characteristics and intra- and postoperative 
data from all patient have been recorded in an institu-
tional database. In particular:
(a) Intraoperative records: re-operation; type 
of operation (coronary artery bypass graft 
(CABG), valvular, CABG and valvular, other); 
priming volume; CPB time; cross-clamp time; 
lowest temperature during CPB; circulatory ar-
rest; diuresis during CPB; need for ultrafiltra-
tion during CPB; number of PRCs transfused; 
peak arterial lactate concentration during CPB; 
lowest haemoglobin (Hb) and haematocrit 
(Hct) values during CPB; arterial and venous 
blood samples for oxygen and carbon dioxide 
derived estimates (see next paragraph).
(b) Postoperative records (during the first three 
postoperative days): peak lactates; estimates of 
renal function (peak sCr level; lowest eGFR; 
acute kidney injury (AKI) stage according to 
the AKIN criteria;7; need for renal replace-
ment therapy); estimates of pulmonary func-
tion (lowest PaO2/FiO2 ratio; duration of ven-
tilation; respiratory failure, defined as either 
one of the following: ventilation >48 hours, 
need for re-intubation or for post-extubation 
non-invasive mechanical ventilation with con-
tinuous positive airway pressure (CPAP) hood 
(StarMed spa, Mirandola, Modena, Italy) [re-
quired if PaO2/FiO2<200 mmHg after having 
excluded any other cause of respiratory fail-
ure, such as pneumothorax, pleural effusion, 
pulmonary embolism]); in-hospital mortality.
Blood samples and calculations
As an institutional protocol, blood gas analysis was per-
formed every 20 minutes from the institution All blood 
gas data were corrected for temperature, according to 
standard equations.
The estimates of oxygen- and carbon dioxide-derived 
parameters have been calculated according to Ranucci 
and associates.1 In particular:
DO2i [mL/min/m2 ] = 10 x pump index  
[L/min/m2 x arterial O2 content [mL/100mL];
VO2i [mL/min/m2] = 10 x pump index [L/min/m2] 
x (arterial – venous O2 content) [mL/100 mL];
Oxygen content [ mL/100 mL] = Hb [mg/dL] x  
1.34 x SO2(arterial/venous)[%] +  
pO2(arterial/venous)[mmHg] x 0.003.
As far as the VCO2i calculation is concerned, expiratory 
CO2 tension (eCO2, mmHg) was measured at the site of 
the oxygenator exhaled gas port with a ventilator-inte-
grated capnograph. Gas volumes and flows are 
expressed in STPD (standard temperature and pressure 
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dry); adequate corrections according to body tempera-
ture pressure saturated (BTPS) conditions were applied 
[Appendix A]. Therefore, VCO2i was calculated as fol-
lows:
VCO2i [mL/min/m2] = (eCO2 [mmHg] x gas flow 
into the oxygenator [L/min] x 10000)/(760 x body sur-
face area)
Aim of the study and design of the score
The main aim of our study was to design a score that 
might correlate the estimate of an adequate perfusion to 
the occurrence of adverse outcomes after surgery on 
CPB. We named it the QualyP Score.
According to reference values already established in 
the current literature, ten parameters were included to 
design this additive score. In particular: peak lactates dur-
ing CPB, peak VCO2i, lowest DO2i/VCO2i, respiratory 
quotient, CPB time, cross-clamp time, lowest CPB tem-
perature, circulatory arrest, ultrafiltration during CPB, 
number of packed red cells transfused intraoperatively 
(during CPB and before admission to the ICU) (Table 1).
The major outcome was considered to be postopera-
tive acidosis (defined as peak lactate >3 mmol/L during 
the first three postoperative days, even on a single blood 
sample); secondary outcomes were incidences of differ-
ent degrees of renal failure (AKIN 1-2-3); respiratory 
failure; mortality. To avoid any interference to the assess-
ment of postoperative hyperlactataemia, Ringer lactate 
was never administered during the study period and 
postoperative blood samples were performed at least 
two hours from any RBC transfusion.
Statistical analysis was performed by the SPSS pro-
gram for Windows, version 15.0 (SPSS Inc, Chicago, IL). 
Continuous variables are presented as mean ± standard 
deviation (SD) and categorical variables are presented as 
absolute numbers and/or percentages. For all statistical 
tests, a p-value <0.05 was considered significant.
All parameters recorded in our database, including 
the QualyP score, were tested for the association with 
the postoperative outcomes with a binary logistic 
regression analysis. To avoid over-fitting, all factors 
being significantly associated (p<0.05) with any out-
come were used to build multivariate stepwise forward 
logistic regression models to establish their independ-
ent predictors.
To avoid multi-co-linearity, variables affected by 
mathematical coupling were separately entered in dif-
ferent models. In case of inter-correlation, the best sin-
gle independent variable was chosen.
Results
Demographics, preoperative variables and intraopera-
tive details are shown in Table 2.
Mean QualyP Score was 4.8±2.6 (0-10).
Postoperative acidosis
Among all 187 patients, a peak postoperative lactate 
concentration >3 mmol/L was observed in 78 patients 
(41.7%).
When recorded variables were tested for associa-
tion with postoperative acidosis, only 11 factors were 
entered into the multivariate model. Among these, 
QualyP Score proved to be an independent predictor 
of postoperative acidosis (OR 1.595, 95% CI 1.356-
1.876) (Table 3). The C-statistic of the model was 
0.798.
The AUC for QualyP Score was 0.780, with a cut-off 
value of 1 (sensibility 98.7%; specificity 98.2%).
Table 1. QualyP Score: values with literature references.
Variables 0 1 2
Peak lactates during CPB 
[mmol/L]1
<3 ≥3 –
Peak VCO2i [ml/min/m2]2 <60 ≥60 –
Peak DO2i/VCO2i2 ≥5 <5 –
Peak VCO2i/VO2i2 <0.9 ≥0.9 –
CPB time [min]3 <126 127–177 >177
Aortic cross-clamping time [min]3 <90 91–131 >131
Lowest temperature on CPB [°C]4 34-36 28-33 <28
Circulatory arrest5 No Yes –
Ultrafiltration for low urine output 
during CPB6
No Yes –
Number of PRCs transfused7 0 1–2 >2
CPB= cardiopulmonary bypass; VCO2i= indexed CO2 production; 
DO2i= indexed O2 delivery; VO2i= indexed O2 consumption; PRC= 
packed red blood cells.
1Maillet J-M, Le Besnerais P, Cantoni M, et al. Frequency, risk 
factors, and outcome of hyperlactatemia after cardiac surgery. Chest 
2003;123:1361-1366.
2Ranucci M, Isgrò G, Romitti F, Mele S, Biagioli B, Giomarelli P. 
Anaerobic metabolism during cardiopulmonary bypass: predictive value 
of carbon dioxide derived parameters. Ann Thorac Surg 2006;81:2189-
2195.
3Data derived from an interim analysis of the first 100 patients. 0 = 
duration until the median time; 1 = duration until 1 standard deviation 
from the median; 2 = duration over 1 standard deviation from the 
median.
4Marx, John (2006). Rosen’s emergency medicine: concepts and clinical 
practice. Mosby/Elsevier. p. 2239.
5Goldstone AB, Bronster DJ, Anyanwu AC, Goldstein MA, Filsoufi 
F, Adams DH, Chikwe J. Predictors and outcomes of seizures after 
cardiac surgery: a multivariable analysis of 2,578 patients. Ann Thorac 
Surg 2011;91:514-518.
6Parolari A, Pesce LL, Pacini D, Mazzanti V, Salis S, Sciacovelli C, 
Rossi F, Alamanni F; Monzino Research Group on Cardiac Surgery 
Outcomes. Risk factors for perioperative acute kidney injury after adult 
cardiac surgery: role of perioperative management. Ann Thorac Surg 
2012;93:584-591.
7Jegger D, Revelly JP, Horisberger J, von Segesser LK, Ruchat P. 
Establishing an association between a peri-operative perfusion score 
system (PerfSCORE) and post-operative patient morbidity/mortality 
during CPB cardiac surgery. Perfusion 2007;22:311-316.
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Renal failure – AKIN 1
Forty-nine patients (26.2%) experienced AKI stage 1. 
However, we could not find any statistical correlation 
with the incidence of AKI stage 1, even at univariate 
binary logistic analysis.
Renal failure – AKIN 2
Sixteen patients (8.6%) fulfilled the criteria to be 
included in AKI stage 2. Among all the tested variables, 
QualyP Score was found to be an independent predictor 
of AKIN 2 (OR 1.268, 95% CI 1.018-1.581) (Table 4). 
The C-statistic of the model was 0.836.
The AUC for QualyP Score was 0.647, with a cut-off 
value of 2 (sensibility 93.8%; specificity 89.5%)
Renal failure – AKIN 3
AKIN stage 3 occurred in only 11 patients (5.9%). At 
multivariate analysis, QualyP Score was an independent 
predictor of AKIN 3 (OR 1.848, 95% CI 1.230-2.778) 
(Table 4). The C-statistic of the model was 0.902.
The area under the curve (AUC) for the QualyP 
Score was 0.794, with a cut-off value of 5 (sensibility 
90.0%; specificity 49.1%).
Respiratory failure
Among all patients, 21 (11.2%) experienced respiratory 
failure. Several independent risk factors have been 
revealed (Table 5). In particular, QualyP Score emerged 
as an independent predictor (OR 1.526, 95% CI 1.123-
2.073), with a cut-off value of 2 (sensibility 95.2% and 
specificity 89.2%).
Mortality
Seven patients died during hospitalization, accounting 
for an overall mortality of 3.7%.
At multivariate analysis, the QualyP Score was an 
independent predictor of mortality (OR 1.497, 95% CI 
1.054-2.127), with a cut-off value of 5 (sensibility 85.7%; 
specificity 50.6%).
However, the PerfSCORE was also an independent 
risk factor for mortality, but only in models where the 
QualyPScore was not included (Table 6).
Discussion
The main aim of cardiopulmonary bypass during car-
diac operations is to warrant an adequate perfusion to 
all the organs so that they can maintain their normal 
functions when the heart is arrested. Accordingly, it is 
Table 2. Demographics, preoperative characteristics and 
operative details.
Variables n=187
Age [years] 64.2±13.2
Gender (M) 114 (61.0%)
Height [cm] 163.6±9.1
Weight [Kg] 72.1±12.7
BSA [m2] 1.80±0.19
BMI [Kg/m2] 26.9±4.0
Smoker or previous smoke habit 70 (37.4%)
COPD 32 (17.2%)
Systemic hypertension 134 (71.7%)
Diabetes (any kind) 52 (27.8%)
Chronic renal insufficiency (not requiring 
preoperative dialysis)
19 (10.2%)
Previous cerebrovascular accidents 14 (7.5%)
Peripheral vascular disease 21 (11.2%)
Unstable angina 23 (12.3%)
Myocardial infarction in the last 90 days 
before surgery
19 (10.2%)
Myocardial infarction >90 days before 
surgery
30 (16.0%)
Previous coronary angioplasty/stenting 20 (10.7%)
NYHA class 3/4 94 (50.3%)
Preoperative inotropes 2 (1.1%)
EuroSCORE II 3.12±3.88
Baseline serum creatinine [mg/dL] 1.1±0.6
Baseline estimated glomerular filtration 
rate [ml/min/1.73 m2]
78.6±27.4
Baseline haemoglobin [g/dL] 12.9±1.7
Baseline haematocrit [%] 38.9±4.7
Baseline PaO2/FiO2 ratio [mmHg] 395.8±106.2
Re-operation 9 (4.8%)
CABG 46 (24.6%)
Valvular 78 (41.7%)
CABG + valvular 32 (17.1%)
Other kind of surgery 32 (17.1%)
Priming volume [ml] 941.8±197.4
CPB time [min] 121.4±47.9
AoX time [min] 88.7±39.2
Lowest temperature during CPB 31.8±2.7
Circulatory arrest 18 (9.6%)
Diuresis during CPB [ml] 1046.8±772.7
Ultrafiltration during CPB 9 (4.8%)
Number of PRCs transfused 0.3±0.7
Peak arterial lactates [mmol/L] 2.0±1.2
Lowest Hb during CPB [g/dl] 7.2±1.2
Lowest Hct during CPB [%] 21.2±3.1
Lowest DO2i [ml/min/m2] 270.4±37.3
Lowest VO2i [ml/min/m2] 54.5±15.2
Peak VCO2i [ml/min/m2] 68.1±24.1
BSA: body surface area (Mosteller); BMI: body mass index; COPD: 
chronic obstructive pulmonary disease; NYHA: New York 
Heart Association; CABG: coronary artery bypass grafting; CPB: 
cardiopulmonary bypass: AoX: aortic cross-clamping; PRCs: packed red 
blood cells; Hb: haemoglobin; Hct: haematocrit; DO2i: indexed delivery 
of oxygen; VO2i: indexed consumption of oxygen; VCO2i: indexed 
carbon dioxide production.
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necessary that the pump flows and gas exchange during 
CPB should be modulated to allow a normal oxygen 
delivery and an adequate elimination of carbon dioxide.
Great attention has been posed in the past on the hae-
moglobin concentration, given that the degree of 
haemodilution during CPB is associated with postopera-
tive complications.3,8 Furthermore, the avoidance of 
extreme haemodilution is strictly correlated to the efforts 
made to avoid the transfusion of packed red cells, which 
is associated with an increased occurrence of infections 
and mortality.4
In 2007, Jegger developed a score to study the asso-
ciation between CPB and clinical outcomes, demon-
strating that the PerfSCORE was an independent 
parameter to predict morbidity.9
However, that score included only the raw values of 
pO2 and pCO2, not considering the role played by pump 
flow to ensure the major part of oxygen delivery, 
Table 3. Multivariate models for postoperative acidosis.
Variables p univariate p multivariate OR 95% CI
EuroSCORE II .002 .006 1.197 1.052–1.361
CPB time <.001 .035 1.017 1.001–1.034
AoX time <.001 .605  
PRCs transfusions during CPB .018 .280  
NIDDM .044 .105  
Dislipidaemia .041 .659  
Surgery type: other .003 .871  
Circulatory arrest .001 .117  
Peak RQ .023 .369  
PerfSCORE <.001 .164  
QualyP Score <.001 <.001 1.595 1.356–1.876
CPB: cardiopulmonary bypass; AoX: aortic cross-clamping; PRCs: packed red blood cells; NIDDM: non-insulin-dependent diabetes mellitus; RQ: 
respiratory quotient.
Table 4. Multivariate models for postoperative AKIN 2 – AKIN 3.
Variables p univariate p multivariate OR 95% CI
AKIN2
Age .002 .008 1.119 1.029–1.216
Baseline Hb .011 .054  
Baseline Hct .040 .553  
QualyP Score .043 .034 1.268 1.018–1.581
BSA .026 .194  
Lowest Hb during CPB .023 .334  
Lowest Hct during CPB .031 .358  
PerfSCORE .108  
AKIN 3
IDDM .038 .897  
Previous PCI/stent .010 .077  
Surgery: CABG+valvular .003 .052  
Baseline sCr .001 .001 27.575 3.617–210.237
QualyP Score .002 .003 1.848 1.230–2.778
EuroSCORE II .006 .815  
Baseline eGFR .005 .928  
CPB time .001 .584  
AoX time .002 .001 1.031 1.012–1.051
PerfSCORE .061  
Hb: haemoglobin; Hct: haematocrit; BSA: body surface area; CPB: cardiopulmonary bypass.
IDDM: insulin-dependent diabetes mellitus; PCI: percutaneous coronary intervention; CABG: coronary artery bypass grafting; sCr: serum creatinine; 
eGFR: estimated glomerular filtration rate; AoX: aortic cross-clamping.
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whereas the possibility to calculate the metabolic needs 
during CPB could be extremely useful in the daily clin-
ical practice.
On the other hand, to the best of our knowledge, this 
is the first study aimed at the evaluation of the quality of 
organ perfusion by means of the development of a scor-
ing system that incorporates the estimates of oxygen 
delivery and consumption during CPB.
In fact, several reports suggest that tissue oxygenation 
and hypoxia could be better evaluated when the flow-
dependent estimates of oxygen delivery and consump-
tion are investigated during CPB, as well as estimates of 
carbon dioxide elimination.1,10,11 Likewise, the same 
principles derived from the normal physiology could be 
applied to the CPB setting, in terms of oxygen- and car-
bon dioxide-derived estimates of the metabolic needs.1
In particular, Ranucci and coworkers demonstrated 
that the threshold for anaerobic metabolism during 
CPB establishes when VCO2i peaks over 60 ml/min/m2, 
VCO2i/VO2i reaches 0.9 and DO2i/VCO2i falls below 5.1 
These models encouraged other researchers to apply 
these concepts in the field of postoperative renal func-
tion after cardiac surgery on CPB. Similarly, equivalent 
cut-off values were found to be predictive of postopera-
tive renal failure.2
However, it is noteworthy that Poullis recently recog-
nized that no markers of quality of perfusion pressure 
and oxygen delivery during CPB still exist. Accordingly, 
correlating such evaluations with clinical outcome could 
prove helpful in providing a marker of quality of perfu-
sion during CPB.11
Therefore, the aim of our QualyP Score was to ascer-
tain if it was possible to evaluate the impact of the qual-
ity of perfusion provided during CPB on postoperative 
outcomes. This scoring system was based on cut-off val-
ues derived from literature, with adjunctive parameters 
resulting from an interim analysis of our first 100 
patients (Table 1).
Table 5. Multivariate models for postoperative respiratory failure.
Variables p univariate p multivariate OR 95% CI
Obesity .018 .006 7.138 1.762-28.913
IDDM .047 .755  
Chronic renal insufficiency .001 .014 6.075 1.432-25.777
Unstable angina .022 .079  
Recent myocardial infarction .006 .018 7.268 1.413-37.393
Age .047 .181  
EuroSCORE II .001 .250  
PerfSCORE .006 .503  
QualyP Score .004 .007 1.526 1.123–2.073
Ultrafiltration during CPB .005 .979  
CPB time <.001 .001 1.041 1.017–1.067
AoX time .009 .044 .970 .942–.999
PRCs transfused during CPB .024 .288  
IDDM: insulin-dependent diabetes mellitus; CPB: cardiopulmonary bypass; AoX: aortic cross-clamping; PRCs: packed red blood cells.
Table 6. Multivariate models for postoperative mortality.
Variables p univariate p multivariate OR 95% CI
Age .009 .036 1.221 1.031-1.472
EuroSCORE II .002 .089  
QualyP Score .007 .024 1.497 1.054-2.127
Ultrafiltration during CPB <.001 .002 39.530 3.907-399.966
Intraoperative PRCs transfusions .037 .480  
PerfSCORE .002 .034 1.695 1.041–2.757
CPB time .044 .390  
Lowest Hb during CPB .018 .947  
Lowest Hct during CPB .029 .838  
Lowest DO2i .040 .759  
Lowest VO2i .042 .987  
CPB: cardiopulmonary bypass; PRCs: packed red blood cells; Hb: haemoglobin; Hct: haematocrit; DO2i: indexed delivery of oxygen; VO2i: indexed 
consumption of oxygen.
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As an estimate of global organ metabolism, serum 
lactate concentration represents the most relevant and 
reliable marker of tissue hypoperfusion. Accordingly, 
the development of high lactate concentrations during 
CPB is typical of a subset of patients at a higher risk of 
incurring potentially severe complications.12 In our 
study, a level of 3 mmol/L was considered the threshold 
for the establishment of an anaerobic metabolism, as 
described by Maillet.13
In the present study, the QualyP Score was predictive 
of postoperative acidosis at a low cut-off, equal to 1. 
Despite high sensitivity and specificity, this value seems 
quite low to explain, by itself, the development of post-
operative anaerobic metabolism. It could be supposed 
that, not only the perfusion during CPB, but also other 
mechanisms (e.g. higher metabolic needs during the 
weaning from ventilation as well as peripheral wash-out 
in the first postoperative hours) might explain this 
increase of serum lactate concentration.
It is general knowledge that the pulmonary damage 
that might develop after CPB usually ends up in the 
development of atelectasis, infections and a increase in 
arterio-venous intrapulmonary shunts, with the conse-
quence of a reduced systemic pO2.14 Moreover, the kind 
of anaesthesia and mechanical ventilation,15,16 the switch 
from a pulsatile flow to a continuous and linear one dur-
ing CPB,17,18 as well as the induction of an ischaemia-
reperfusion injury14 may all contribute to the reduction 
of postoperative pulmonary function.
Accordingly, the possibility to identify intraopera-
tively a perfusion disadvantage which might end up in 
reduced postoperative pulmonary function, would be 
certainly welcome. Appropriately, the QualyP Score 
proved to be predictive of the development of respira-
tory insufficiency in the immediate postoperative 
period. Therefore, it could be supposed that a preco-
cious identification of patients at high-risk for major 
complications might be helpful for subsequent postop-
erative management.
Among all organs, the kidneys are certainly those 
which mostly suffer from hypoperfusion.19,20 Accordingly, 
various degrees of renal dysfunction are often observed in 
the common practice after cardiac operations on CPB.21 
In particular, the development of postoperative renal fail-
ure is one of the most important determinants of unfa-
vorable outcome in cardiac surgery.21
It should be considered that some preoperative char-
acteristics could not be modified before surgery, such as 
age, diabetes, hypertension or preoperative renal dys-
function. However, it is possible to avoid renal hypoper-
fusion, which is, in particular, one of the major 
determinants of the need for postoperative replacement 
therapy.20
In our cohort of patients, the QualyP Score was found 
to be particularly associated with various degrees of 
postoperative renal dysfunction, in particular, AKI stage 
2 and 3. Our results, therefore, confirm the previous 
findings of de Somer2 and Ranucci,20 suggesting that the 
analysis of a broad spectrum of estimate parameters 
could be useful in establishing the adequacy of perfu-
sion.
Conversely, we were not able to confirm the results 
shown by Ranucci20 and de Somer,2 particularly for what 
concerns the predictive role of DO2i/VCO2i on the 
occurrence of postoperative renal dysfunction. On the 
other hand, our results confirmed our hypothesis that 
not one single parameter, but the comprehensive evalu-
ation of tissue hypoperfusion which can be measured by 
oxygen and carbon dioxide derived parameters, is 
responsible for the occurrence of postoperative compli-
cations.
In particular, it should be considered that 3 out of 10 
parameters constituting the additive QualyP Score are 
directly dependent from the pump flow. This suggests 
that modulation of the pump flow plays a fundamental 
role in achieving an adequate perfusion during CPB.
Finally, the complex pathophysiology that is gener-
ated during cardiac surgery on CPB (e.g. hypother-
mia, systemic inflammatory response syndrome, 
endothelial dysfunction, deregulation of the haemo-
coagulative cascade, linear flow patterns) all contrib-
ute to the development of postoperative complications, 
sometimes irreversibly leading to the most unfavora-
ble outcome.14
However, it is still not evident which role is indepen-
dently played by CPB on postoperative mortality.22
In fact, de Somer supposed that the development of 
different perfusion strategies combined with adequate 
pharmacological support might improve the incidence 
of CPB-related morbidity;22
however, no statistical models, as well as scores pre-
dictive of postoperative outcomes, have been clearly 
designed especially incorporating flow-dependent 
parameters.
In this setting, the QualyP Score and the results 
derived from our study could be analyzed as a potential 
marker of the quality of perfusion, as well as a predictive 
model of postoperative mortality.
Limitations of the study
One of the most important limitations of the study is the 
relatively low incidence of outcomes observed during 
the study period. This may be accounted for by the small 
sample size. Furthermore, the overall EuroSCORE II of 
the study population is quite low and this might have 
conditioned the results, considering that patients with 
severe comorbidities (such as chronic renal replacement 
therapy or domicilial O2 support) were excluded from 
the study.
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The lack of a validation cohort is another limitation 
of the study. However, to try to overcome this problem, 
we have used reference values from well-established 
papers from the literature whose results have been found 
to be confirmed elsewhere.
However, all the multivariate models proved to be 
sufficiently powered, at least to draw some preliminary 
conclusions. It should also be noted that the high sensi-
tivity of the cut-off values observed for the outcomes of 
AKIN 3 and mortality are counterbalanced by a rela-
tively low specificity, suggesting that a revision of the 
scoring system might probably improve the quality of 
the model itself.
Furthermore, the absence of reference cut-off levels 
for our QualyP Score prevented a power sample analysis.
On the other hand, one of the main strengths of our 
study is that our results stem from a single institution 
design of the study, which guarantees the uniformity of 
intraoperative and postoperative treatments and, there-
fore, might counterbalance the potential biases of multi-
centre studies.
Conclusions
Despite the continuous improvements in the perfusion 
techniques since the beginning of the experience with 
CPB, it is still not possible to benchmark the quality of 
perfusion during cardiac surgery on CPB.
It could be supposed that the technological progress 
(more biocompatibility of membranes and circuits, fil-
ters, pulsatile or modulated flows) might improve the 
impact of fixed major determinants during cardiac sur-
gery. However, this may not be sufficient alone.
It is evident that the development of monitoring sys-
tems could suggest the appropriate warnings and clues 
during CPB to avoid the development of organ dysfunc-
tion as a consequence of an inadequate intraoperative 
perfusion.
Furthermore, evidence-based medicine is emerging 
nowadays as a new paradigm for medical practice, 
including the field of extracorporeal circulation.5
In this setting, the development of scoring systems, 
such as the QualyP Score, might represent an advantage 
and a first step towards the definition of goal-directed 
perfusion strategies and quality benchmarking.
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Appendix A. Conversion equations for volumes of a gas.
From To Multiply APTS by
ATPS STPD [(PA - PwaterS)/PS] * (TS - TA)
ATPS BTPS [(PA - PwaterS)/ (PA - PwaterB)] * (TB - TA)
PA: ambient pressure; PwaterS: partial pressure of water in saturated air; PS: standard pressure (760 mmHg); TS: standard temperature in Kelvin (273 
K); TA: ambient temperature in Kelvin (t °C + 273 K); PwaterB: partial pressure of water in saturated air in 37 °C = 47 mmHg; TB: body temperature.
Adapted from Brown SP, Miller WC, Eason JM (2006). Exercise Physiology: Basis of Human Movement in Health and Disease. Lippincott Williams & 
Wilkins. p. 113.
